Patents by Inventor Werner Baschong
Werner Baschong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10098849Abstract: Compounds of the formulae and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of the formula wherein G1 is hydrogen; C1-C22alkyl; C1-C22alkylthio; C2-C22alkylthioalkyl; C5-C7cycloalkyl; phenyl; C7-C9-phenylalkyl; or SO3M; G2 is C1-C22alkyl; C5-C7cycloalkyl; phenyl; or C7-C9-phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G3 are as defined in claim 1; G4 and G5 are each independently of the other hydrogen; or C1-C22alkyl; exhibit marked antiinflammatory action.Type: GrantFiled: September 5, 2012Date of Patent: October 16, 2018Assignee: BASF SEInventors: Werner Baschong, Oliver Reich, Sébastien Mongiat
-
Patent number: 8383088Abstract: The present invention relates to derivatives of the 1H-pyrano[4,3-b]benzofuran-1-one structure and their nitrogen analogues which possess powerful antioxidant properties combined with a highly effective UV absorbing functionality in one molecule. These compounds are especially useful in cosmetical and dermatological formulations.Type: GrantFiled: February 29, 2008Date of Patent: February 26, 2013Assignee: BASF SEInventors: Barbara Wagner, Sébastien Mongiat, Bernd Herzog, Werner Baschong, Andreas Buthe, Reinhold Öhrlein
-
Publication number: 20120328541Abstract: Compounds of the formulae and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of the formula wherein G1 is hydrogen; C1-C22alkyl; C1-C22alkylthio; C2-C22alkylthioalkyl; C5-C7cycloalkyl; phenyl; C7-C9-phenylalkyl; or SO3M; G2 is C1-C22alkyl; C5-C7cycloalkyl; phenyl; or C7-C9-phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G3 are as defined in claim 1; G4 and G5 are each independently of the other hydrogen; or C1-C22alkyl; exhibit marked antiinflammatory action.Type: ApplicationFiled: September 5, 2012Publication date: December 27, 2012Inventors: Werner Baschong, Oliver Reich, Sébastien Mongiat
-
Publication number: 20120093896Abstract: The invention describes the use of a nanodispersion, which comprises: a) a membrane-forming molecule, b) a co-emulsifier, c) a lipophilic component, and d) a water-soluble ingredient sensitive to oxidation in cosmetic end formulations, the nanodispersion being obtainable by (?) mixing the components (a), (b) and (c) until a homogeneous liquid is obtained (so-called nanodispersion pre-phase), and (?) adding the water or aqueous phase (discontinuous phase) which contains the water-soluble ingredient and optionally the non-aqueous polar organic solvent to the liquid obtained in step (?). Component (d) is preferably ascorbic acid or vitamin C.Type: ApplicationFiled: July 22, 2008Publication date: April 19, 2012Applicant: CIBA CORPORATIONInventors: Sébastien Mongiat, Julie Grumelard, Werner Baschong, Bernd Herzog
-
Publication number: 20100330009Abstract: The present invention relates to derivatives of the 1H-pyrano[4,3-b]benzofuran-1-one structure and their nitrogen analogues which possess powerful antioxidant properties combined with a highly effective UV absorbing functionality in one molecule. These compounds are especially useful in cosmetical and dermatological formulations.Type: ApplicationFiled: February 29, 2008Publication date: December 30, 2010Applicant: CIBA CORPORATIONInventors: Barbara Wagner, Sebastien Mongiat, Bernd Herzog, Werner Baschong, Andreas Buthe, Reinhold Ohrlein
-
Publication number: 20090258041Abstract: Formulations for cosmetical or pharmaceutical use contain an antioxidant in encapsulated form and a cosmetically or pharmaceutically acceptable carrier. The antioxidant is selected from carbon bridged hindered phenoles, ester bridged hindered phenoles, amide bridged hindered phenoles, lactones of hindered phenoles, sterically hindered oxylamines and sterically hindered hydroxylamines. The encapsulated antioxidant is of high activity and suitable to protect a further active ingredient, e.g. oxidizable natural substances, vitamins, fragrances, and extracts from plants fungi, algae or animals, from premature degradation, especially when coencapsulated together with the ingredient. The formulations are useful inter alia for the preparation of a cosmetical or pharmaceutical skin care or skin delivery formulation, injectable solution, infusion solution, eye drop, drinking solution, a dietary or enriched food, an oral care formulation, drinking gargles, in-halants, or as a food additive.Type: ApplicationFiled: June 21, 2006Publication date: October 15, 2009Inventors: Sebastien Mongiat, Werner Baschong, Bernd Herzog
-
Publication number: 20090156563Abstract: A cosmetic or pharmaceutical composition is provided comprising: a) 0.001 to less than 0.2% by weight, based on the weight of the total composition, of a scleroglucan having a mean molecular weight of 1×106 to 12×106; b) a cosmetically or pharmaceutically acceptable carrier; and, optionally, c) lactic acid, a lactate and/or pentanediol. The composition shows advantageous effects, such as moisturization of skin or mucosa, and has an antiaging and revitalizing effect on the skin. When combined with a certain bactericide as explained in claim 1, compositions containing native polysaccharides of the glucan class in general, especially of the scleroglucan as of component a), are well suitable to reduce the number of bacteria in mucosal or oral environments and minimise adhesion, while retaining a pleasant feeling on the mucosa or gingiva. Plaque thus can be efficiently prevented or removed.Type: ApplicationFiled: November 20, 2006Publication date: June 18, 2009Inventors: Werner Baschong, Sebastien Mongiat, Dietmar Ochs
-
Publication number: 20080305055Abstract: Compounds of the formulae (1), (2) and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of formula (3), wherein Gi is hydrogen; C1-C22alkyl; C1-C22alkylthio; C2-C22alkylthioalkyl; C5-C7cycloalkyl; phenyl; C7-C9phenylalkyl; or SO3M; G2 is C1-C22alkyl; C5-C7cycloalkyl; phenyl; or C7-C9phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G3 are as defined in claim 1; G4 and G5 are each independently of the other hydrogen; or C1-C22alkyl; exhibit marked antiinflammatory action.Type: ApplicationFiled: October 24, 2005Publication date: December 11, 2008Inventors: Werner Baschong, Oliver Reich, Sebastien Mongiat
-
Publication number: 20080279794Abstract: The use of (a) hydroxydiphenyl ether compounds of formula ?wherein R1, R2 and R3 are each independently of the others hydrogen; hydroxy; C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; C1-C20alkoxy; C1-C6alkylcarbonyl; phenyl; or phenyl-C1-C3alkyl; R4 is hydrogen, C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; hydroxy; formyl; acetonyl; allyl; carboxy; carboxy-C1-C3alkyl; carboxyallyl; C2-C20alkenyl; C1-C6alkylcarbonyl; C1-C3alkylcarbonyl-C1-C3alkyl; phenyl; or phenyl-C1-C3alkyl; and R5 is hydrogen; C1-C20alkoxy; or C1-C6alkylcarbonyl; as melanogenesis inhibitors and for lightening the skin.Type: ApplicationFiled: June 24, 2008Publication date: November 13, 2008Inventors: Werner Baschong, Marcel Schnyder
-
Publication number: 20080260667Abstract: The use of (a) hydroxydiphenyl ether compounds of formula wherein R1, R2 and R3 are each independently of the others hydrogen; hydroxy; C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; C1-C20alkoxy; C1-C6alkylcarbonyl; phenyl; or phenyl-C1-C3alkyl; R4 is hydrogen, C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; hydroxy; formyl; acetonyl; allyl; carboxy; carboxy-C1-C3alkyl; carboxyallyl; C2-C20alkenyl; C1-C6alkylcarbonyl; C1-C3alkylcarbonyl-C1-C3alkyl; phenyl; or phenyl-C1-C3alkyl; and R5 is hydrogen; C1-C20alkoxy; or C1-C6alkylcarbonyl; as melanogenesis inhibitors and for lightening the skin.Type: ApplicationFiled: June 19, 2008Publication date: October 23, 2008Inventors: Werner Baschong, Marcel Schnyder
-
Patent number: 7425320Abstract: The use is described of compositions comprising (a) (?)-guaiol, (b) further skin-lightening active substance(s) and, optionally, (c) one or more UV-A and/or UV-B absorbers as melanogenesis inhibitors and for skin-lightening.Type: GrantFiled: September 10, 2002Date of Patent: September 16, 2008Assignee: Ciba Specialty Chemicals CorpInventors: Werner Baschong, Gerd Heinemann, Dietmar Ochs
-
Publication number: 20070219275Abstract: The invention describes the use of organic UV filters of formula (I) wherein R, and R2, 'independently from each other are hydrogen, C1-C2, alkyl, C2-C10 alkenyl, C3 C,ocycloalkyl, C3-C10cycloalkenyl, or R, and. R2 togethér with the nitrogen atom to which they are bonded can form a 5- or 6-membered ring; R3 and R4, independently from each other are C1-C20alkyl, C2 C,oalkenyl, C3-C12cycloalkyl, C3-C10cycloalkenyl, C1-C12alkoxy, C,-C20alkoxycarbonyl, C1-C,zalkylamino, C1-C12dialkylamino, aryl, heteroaryl, optionally substituted, substituents which confer solubility in water, chosen from the group consisting of a nitrile group, carboxylate, sulfonate or ammonium radicals; X is hydrogen, COOR5, CONR6R7; R5, Rs and R7, independently from each other are hydrogen, C1-C20alkyl, C2-C10alkenyl, C3-C,0cycloalkyl, C3 C10cycloalkenyl, (Y-0), -Z-aryl; Y is —(CH2)2, —(CH2)3, —(CH2)4—, —CH(CH3)—CH2; Z is —CH2 CH3i —CH2—CH,CH3, —CH2 CH2 CH2 CH3, —CH(CH3)—CH,; m is from 0 to 3; n.Type: ApplicationFiled: March 23, 2005Publication date: September 20, 2007Inventor: Werner Baschong
-
Publication number: 20060216252Abstract: The use of hydroxydiphenyl ether compounds of formula (I), wherein R1, R2 and R3 are each independently of the others hydrogen; hydroxy; C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; C1-C20alkoxy; C1-C6alkylcarbonyl; phenyl; or phenyl-C1-C3alkyl; R4 is hydrogen, C1-C20alkyl; hydroxy-substituted C1-C20alkyl; C5-C7cycloalkyl; hydroxy; formyl; acetonyl; allyl; carboxy; carboxy-C1-C3alkyl; carboxyallyl; C2-C20alkenyl; C1-C6alkylcarbonyl; C1-C3alkylcarbonyl-C1-C3alkyl; phenyl; or phenyl-C1-C3alkyl; and R5 is hydrogen; C1-C20alkoxy; or C1-C6alkylcarbonyl; as melanogenesis inhibitors and for lightening the skin.Type: ApplicationFiled: July 7, 2004Publication date: September 28, 2006Applicant: CIBA SPECIALTY CHEMICALS HOLDING INC.Inventors: Werner Baschong, Marcel Schnyder
-
Publication number: 20050058610Abstract: The use is described of compositions comprising (a) (?)-guaiol, (b) further skin-lightening active substance(s) and, optionally, (c) one or more UV-A and/or UV-B absorbers as melanogenesis inhibitors and for skin-lightening.Type: ApplicationFiled: September 10, 2002Publication date: March 17, 2005Inventors: Werner Baschong, Gerd Heinemann, Dietmar Ochs
-
Publication number: 20030229149Abstract: Disclosed is the use of hydroxydiphenylether compounds of formula 1Type: ApplicationFiled: May 23, 2003Publication date: December 11, 2003Inventors: Werner Baschong, Helmut Luther, Dietmar Ochs, Sebastien Mongiat
-
Publication number: 20030068347Abstract: The use of microbially encapsulated materials (filled biocapsules), in particular yeast, in cosmetic end formulations is described.Type: ApplicationFiled: July 8, 2002Publication date: April 10, 2003Inventors: Werner Baschong, Dietmar Huglin
-
Patent number: 6514950Abstract: A description is given of the use of polyanionic and polyanionically-derivatised natural polysaccharides or non-derivatised natural polysaccharides for inhibiting alkaline phosphatase and of oral compositions for preventing bacterial plaque, which comprises (a) 0 to 10% by weight of at least one linear molecularly dehydrated polyphosphate salt, and (b) 0.0001 to 5% by weight of a polyanionic or polyanionically-derivatised natural polysaccharide.Type: GrantFiled: June 19, 2000Date of Patent: February 4, 2003Assignee: Ciba Specialty Chemicals CorporationInventors: Werner Baschong, Dietmar Hüglin, Peter Fankhauser, Gerd Heinemann
-
Patent number: 6495122Abstract: The invention describes the use of micronized organic UV filters for preventing tanning and for lightening human skin and hair, and their use in cosmetic and pharmaceutical formulations. The micronized UV filters used according to the invention cover a broad UV spectrum and therefore have excellent sunscreen properties.Type: GrantFiled: February 4, 2002Date of Patent: December 17, 2002Assignee: Ciba Specialty Chemicals CorporationInventors: Peter Fankhauser, Helmut Luther, Werner Baschong
-
Publication number: 20020155073Abstract: The invention describes the use of micronized organic UV filters for preventing tanning and for lightening human skin and hair, and their use in cosmetic and pharmaceutical formulations.Type: ApplicationFiled: February 4, 2002Publication date: October 24, 2002Inventors: Peter Fankhauser, Helmut Luther, Werner Baschong